RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 1,909 followers.

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells v... https://t.co/NSpQDoj84k

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.